Cargando…
Synthesis of positive plasmas with known chromosomal abnormalities for validation of non-invasive prenatal screening
Non-invasive prenatal screening (NIPS) is a DNA sequencing-based screening test for fetal aneuploidies and possibly other pathogenic genomic abnormalities, such as large deletions and duplications. Validation and quality assurance (QA) of this clinical test using plasmas with and without targeted ch...
Autores principales: | Qi, Zhongxia, Yu, Jingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886268/ https://www.ncbi.nlm.nih.gov/pubmed/36726805 http://dx.doi.org/10.3389/fgene.2023.971087 |
Ejemplares similares
-
Editorial: Unravelling the basis of non-invasive prenatal screening results
por: De Falco, Luigia, et al.
Publicado: (2023) -
Clinical experience of noninvasive prenatal testing for rare chromosome abnormalities in singleton pregnancies
por: Hu, Ting, et al.
Publicado: (2022) -
A retrospective single-center analysis of prenatal diagnosis and follow-up of 626 chinese patients with positive non-invasive prenatal screening results
por: Bu, Xiufen, et al.
Publicado: (2022) -
Evaluating the Clinical Utility of Genome Sequencing for Cytogenetically Balanced Chromosomal Abnormalities in Prenatal Diagnosis
por: Yu, Mullin Ho Chung, et al.
Publicado: (2021) -
Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements
por: Sun, Bo-lan, et al.
Publicado: (2023)